Rchr
J-GLOBAL ID:200901099149703378   Update date: Jul. 15, 2020

Tatsumi Tomohide

タツミ トモヒデ | Tatsumi Tomohide
Affiliation and department:
Job title: Associate Professor
Research field  (1): Gastroenterology
Research keywords  (3): Cancer Immunology ,  Hepatology ,  Gatsroenterology
Research theme for competitive and other funds  (1):
  • -
Papers (177):
  • Katsuhiko Sato, Hayato Hikita, Yuta Myojin, Kenji Fukumoto, Kazuhiro Murai, Sadatsugu Sakane, Takeshi Tamura, Takuo Yamai, Yasutoshi Nozaki, Teppei Yoshioka, Takahiro Kodama, Minoru Shigekawa, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara. Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels. PloS one. 2020. 15. 7. e0235573
  • Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Ayako Urabe, Yuki Tahata, Masahide Oshita, Kazuyoshi Ohkawa, Eiji Mita, Hideki Hagiwara, Shinji Tamura, Toshifumi Ito, Takayuki Yakushijin, Sadaharu Iio, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara. Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension. Hepatology research : the official journal of the Japan Society of Hepatology. 2020
  • Naoki Morishita, Ryotaro Sakamori, Tomomi Yamada, Yugo Kai, Yuki Tahata, Ayako Urabe, Ryoko Yamada, Takahiro Kodama, Hayato Hikita, Yoshinori Doi, Shinji Tamura, Hideki Hagiwara, Yasuharu Imai, Sadaharu Iio, Tomohide Tatsumi, Tetsuo Takehara. Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infection. PloS one. 2020. 15. 6. e0234811
  • Takuo Yamai, Hayato Hikita, Makoto Fukuoka, Keisuke Fukutomi, Kazuhiro Murai, Tasuku Nakabori, Ryoko Yamada, Kei Miyakawa, Kohei Watashi, Akihide Ryo, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara. SIRT1 enhances hepatitis virus B transcription independent of hepatic autophagy. Biochemical and biophysical research communications. 2020. 527. 1. 64-70
  • Tadashi Kegasawa, Ryotaro Sakamori, Kazuki Maesaka, Ryoko Yamada, Yuki Tahata, Ayako Urabe, Takahiro Kodama, Hayato Hikita, Kazuho Imanaka, Kazuyoshi Ohkawa, Naoki Hiramatsu, Masahide Oshita, Yukinori Yamada, Masami Inada, Takayuki Yakushijin, Yasuharu Imai, Tomohide Tatsumi, Tetsuo Takehara. Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib on Hepatocellular Carcinoma. Digestive diseases and sciences. 2020
more...
MISC (440):
  • 小玉 尚宏, 末村 茂樹, 明神 悠太, 疋田 隼人, 阪森 亮太郎, 巽 智秀, 竹原 徹郎. がん免疫療法において適切な併用薬選択と副作用軽減に関わるバイオマーカー 肝細胞癌に対するレゴラフェニブ治療効果予測因子のCRISPR遺伝子スクリーニングによる探索とHippo経路の同定(Biomarkers to select the best combination therapy and to reduce the adverse events in cancer immunotherapy CRISPR loss-of-function screen identifies the Hippo pathway as the potential efficacy biomarker of regorafenib in HCC). 日本癌学会総会記事. 2019. 78回. S3-5
  • 牧野 祐紀, 疋田 隼人, 小玉 尚宏, 阪森 亮太郎, 巽 智秀, 竹原 徹郎. 肝細胞におけるp53の過剰な活性化は肝前駆細胞を活性化し肝発癌を促進する(Overactivation of hepatocyte p53 activates hepatic progenitor cells and promotes hepatocarcinogenesis). 日本癌学会総会記事. 2019. 78回. E-3067
  • 塩出 悠登, 小玉 尚宏, 疋田 隼人, 阪森 亮太郎, 巽 智秀, 竹原 徹郎. トランスポゾンスクリーニングを用いた胆管細胞がん発症を制御する新規癌遺伝子の同定(Cancer gene discovery of cholangiocellular carcinoma using transposon insertional mutagenesis screen in mice). 日本癌学会総会記事. 2019. 78回. P-3306
  • 山井琢陽, 重川稔, 佐藤悠, 岡部純弥, 田村猛, 佐藤克彦, 占部真貴子, 須田貴広, 吉岡鉄平, 阪森亮太郎, 巽智秀, 竹原徹郎. EUS-FNAにて診断し得た膵悪性リンパ腫の一例. 膵臓(Web). 2019. 34. 3. A356-A357(J-STAGE)
  • 重川稔, 吉岡鉄平, 山井琢陽, 須田貴広, 佐藤克彦, 占部真貴子, 田村猛, 岡部純弥, 佐藤悠, 阪森亮太郎, 巽智秀, 竹原徹郎. EUS-FNA時のneedle tract seedingにより胃壁内転移を来した膵尾部癌の1例. 膵臓(Web). 2019. 34. 3. A325-A326(J-STAGE)
more...
Awards (2):
  • 2010 - The Japan Society of Hepatology 「CHUGAI Award」3rd
  • 2000 - The 8th Hamanako Sypojium Research Award
Association Membership(s) (4):
JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY ,  The Japan Society of Hepatology ,  The Japanese Society of Gastroenterology ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page